🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀 Are you a passionate professional about headaches? Boost your CV, gain peer review skills, and connect with experts! Who can apply? - Researchers and healthcare providers interested in headache. - No prior peer review

Migraine is a debilitating neurological disorder affecting over 1 billion people, about 14–15% of the global population. Women are three times more likely to be affected, highlighting a major gender disparity. In this Episode 1 'Pain & Prejudice', Anette shares her lifelong

June is #MigraineAwarenessMonth! Did you know that #migraine with aura is associated with a higher risk of ischemic stroke? Migraine with aura accounts for 1/5 to 1/3 of migraine patients. The IHS Visual Aura Table helps clinicians and researchers identify and characterize

🎉 Congratulations to the exceptional early-career researchers who have completed the 2024 - 2025 Cephalalgia Reviewer Academy! 👏 This inaugural cohort has demonstrated excellence, dedication, and a deep commitment. 👏 A heartfelt thank you to our outstanding mentors - Anna

🧬 New insights into abdominal migraine in adults Abdominal migraine is rarely diagnosed in adults, leaving treatment options unclear. This case report suggests that CGRP-targeting therapies can lead to substantial symptom relief. 📉 The patient saw up to a 78% reduction in

🧠 New study alert! Headache disorders are a major but underrecognized issue in the workplace. 🔍 In a palm plantation in Cameroon, 80% of workers reported headaches in the past year. ⚠️ Migraine was the most disabling—causing the highest rates of absenteeism, presenteeism,

🚨 New Editorial in Cephalalgia 🚨 "Raising the bar in migraine prevention: Toward freedom and optimal control" by Antonio Russo & Uwe Reuter challenges us to rethink success in migraine care. 🔹 Moving beyond ≥50% MMD reduction 🔹 Emphasizing residual burden and quality of

🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin

🔬 After the breakthrough of CGRP-targeted treatments, what’s next in migraine research? 📌 Emerging evidence suggests amylin—a peptide in the same family as CGRP—may play a role in migraine pathophysiology. 🧠 This new review explores: ✔️ Amylin’s link with CGRP signaling ✔️

🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀 Are you a passionate professional about headaches? Boost your CV, gain peer review skills, and connect with experts! Who can apply? - Researchers and healthcare providers interested in headache. - No prior peer review

🎬 Episode 2 of the IHS documentary Headed for the Future is here! On 13 June, we premiere Episode 2: “Pain Without Gain” on the IHS YouTube channel. Migraine is a serious health condition with major workplace consequences, draining an estimated €50 billion from the

🧠 RCVS and unusual triggers: a case to reflect on Reversible cerebral vasoconstriction syndrome (RCVS) is a rare cause of thunderclap headache, often linked to exertion, stress, or vasoactive exposures. A new case highlights a previously undocumented trigger—underscoring the

🧠 New study alert! Headache disorders are a major but underrecognized issue in the workplace. 🔍 In a palm plantation in Cameroon, 80% of workers reported headaches in the past year. ⚠️ Migraine was the most disabling—causing the highest rates of absenteeism, presenteeism,

June is #MigraineAwarenessMonth! Do you know there are clear criteria for diagnosing migraine? The ICHD‑3 criteria, developed by the International Headache Society’s Classification Committee, give clinicians a clear guide for diagnosing headache disorders. Swipe the

Cephalalgia Editor's choice - May We are pleased to announce and congratulate the authors for their paper: Ku D, Mao L, Nikolova S, Dumkrieger GM, Ross KB, Huentelman M, Anderson T, Porreca F, Navratilova E, Starling A, Wu T, Li J, Chong CD, Schwedt TJ. Longitudinal analysis of

🧠 Post-Traumatic Headache: Tracking Brain Recovery New article published in Cephalalgia: doi.org/10.1177/033310… Why do some patients recover from post-traumatic headache (PTH) after mild traumatic brain injury, while others continue to suffer for months or years? This

🧪 New biomarker insights in migraine! A cross-sectional study of over 750 adults reveals: 🔹 Serum GFAP levels are modestly but significantly higher (+6.8%) in people with migraine vs. healthy controls. 🔹 Serum NfL levels? No difference found. 🔹 Results were independent of

🧠 New in Cephalalgia: Behavioral approaches to post-traumatic headache Persistent post-traumatic headache (PPTH) is a common and disabling consequence of mild traumatic brain injury — yet treatment remains challenging. 🔍 This systematic review (n=12 studies; 2293 individuals)

📢 New publication alert! “Intact white matter in adults with migraine: A REFORM MRI study” 🧠 Using advanced diffusion tensor imaging (DTI), this large case-control study of nearly 300 migraine patients found no significant differences in white matter integrity compared to

🗣️ A powerful patient voice in the migraine conversation In response to "Setting Higher Standards for Migraine Prevention" by Sacco et al., Alleanza Cefalalgici (Al.Ce.), Italy’s national headache patient advocacy group, express strong support for this cultural shift in migraine